Theresa W Gillespie
Overview
Explore the profile of Theresa W Gillespie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cui X, Zhu Y, Zeng L, Zhang M, Uddin A, Gillespie T, et al.
Adv Sci (Weinh)
. 2025 Jan;
:e2407494.
PMID: 39868848
Triple-negative breast cancer (TNBC) in obese patients remains challenging. Recent studies have linked obesity to an increased risk of TNBC and malignancies. Through multiomic analysis and experimental validation, a dysfunctional...
2.
Min Feng Ooi B, Muschialli L, Kondal D, Andia G, Ng Ho Tsun I, Huang H, et al.
Prev Med Rep
. 2024 Sep;
46:102883.
PMID: 39309700
Introduction: Region-specific data on individual factors associated with uptake of breast and cervical cancer screening or early testing in diverse Indian populations are limited. Aim: To assess the prevalence and...
3.
Kulkarni S, Patel S, Sun Y, Jani A, Gillespie T, McDonald M, et al.
Int J Part Ther
. 2024 Sep;
13:100627.
PMID: 39296493
Purpose: Previous studies have shown that external beam radiation therapy is associated with an increased risk of second primary cancer (SPC) among prostate cancer (PCa) patients, but the relative risks...
4.
Ajay P, Mavani P, Sok C, Goyal S, Switchenko J, Gillespie T, et al.
J Surg Oncol
. 2024 Aug;
130(5):1078-1091.
PMID: 39190495
Background: To determine the optimal multimodal treatment strategy between perioperative chemotherapy (PEC), postoperative chemoradiation therapy (POCR), and postoperative chemotherapy (POC) in resected gastric cancer (GC) patients based on nodal status....
5.
Schuster A, Crossnohere N, Adjei Boakye E, Angove R, Baldwin B, Barreto E, et al.
Patient
. 2024 Jun;
18(1):89-95.
PMID: 38909128
No abstract available.
6.
Zhu Y, Banerjee A, Xie P, Ivanov A, Uddin A, Jiao Q, et al.
J Clin Invest
. 2024 Mar;
134(10).
PMID: 38530357
Despite widespread utilization of immunotherapy, treating immune-cold tumors remains a challenge. Multiomic analyses and experimental validation identified the OTUD4/CD73 proteolytic axis as a promising target in treating immune-suppressive triple negative...
7.
Ajay P, Sok C, Goyal S, Switchenko J, Maegawa F, Gillespie T, et al.
J Surg Oncol
. 2023 Apr;
128(2):242-253.
PMID: 37114465
Background: Patients with resectable noncardia gastric cancer may be subjected to perioperative chemotherapy (PEC), postoperative chemoradiation (POCR), or postoperative chemotherapy (POC). We analyzed these treatment strategies to determine optimal therapy...
8.
Aggarwal A, Rama R, Dhillon P, Deepa M, Kondal D, Kaushik N, et al.
BMJ Open
. 2023 Mar;
13(3):e068644.
PMID: 36878651
Objectives: In resource-constrained settings, cancer epidemiology research typically relies on self-reported diagnoses. To test a more systematic alternative approach, we assessed the feasibility of linking a cohort with a cancer...
9.
Bonanno A, Dixon M, Binongo J, Force S, Sancheti M, Pickens A, et al.
Ann Thorac Surg
. 2022 Dec;
115(4):854-861.
PMID: 36526007
Background: Esophagectomy is an important, but potentially morbid, operation used to treat benign and malignant conditions that may significantly impact patient quality of life (QOL). Patient-reported outcomes (PROs) are measures...
10.
Lipscomb J, Switchenko J, Flowers C, Gillespie T, Wortley P, Bayakly A, et al.
Leuk Lymphoma
. 2022 Oct;
64(1):151-160.
PMID: 36308021
For people living with HIV (PLWH) who are subsequently diagnosed with non-Hodgkin lymphoma (NHL), we investigate the impact of standard-of-care (SoC) cancer treatment on all-cause, NHL-specific, and HIV-specific survival outcomes....